Psychological Predictors of Untimely Visit of Prostate Cancer Patients for Oncological Treatment

Among oncological diseases, prostate cancer ranks third after lung and stomach cancer. A timely (early) application of patients for medical help, early diagnosis and early treatment are the factors of a favourable course and survival rate. The purpose of the study is to identify a set of psychological predictors associated with untimely primary care-seeking in men with prostate cancer. 81 men diagnosed with prostate cancer took part in the study, aged from 53 to 85 years old (mean age — 64.4, standard deviation — 8.8), 42 men at early stages of the disease (I, II), 39 men at late stages (III, IV), who first sought professional medical help in the Chelyabinsk Regional Clinical Centre of Oncology and Nuclear Medicine, Chelyabinsk, Russia. Seeking medical help at the early stages of the disease (I, II stages) is timely, or an early application, while treatment at later stages (III, IV) is late treatment. The study used survey methods, in particular, psychodiagnostic techniques: the World Assumptions Scale (R. Janoff-Bulman; adapted by M.A. Padun, A.V. Kotelnikova), the Level of Subjective Control method (E.F. Bazhin, E.A. Golynkina, L.M. Etkind), the Life Orientation Test (M.F. Scheier, C.S. Carpenter, adapted by D.A. Tsiring, K.Y. Evnina), the S. Maddi test of resilience, adapted by D.A. Leontiev, E.I. Rasskazova, the SF-36 “Quality of Life Assessment” questionnaire (the translation into Russian and the approbation of the methodology was carried out by the Institute of Clinical and Pharmacological Research, St. Petersburg). The study found that men who do not seek medical help in a timely manner experience intense pain that interferes with their daily activity, they are also internalized in the field of industrial relations, showing more personal responsibility for successes and failures in the professional sphere. Also, men with prostate cancer who seek help in the late stages of the disease are close to a pessimistic expectation of the future.

1. Amirdzhanova V.N., Goryachev D.V., Korshunov N.I. et al. Populyatsionnye pokazateli kachestva zhizni po oprosniku SF-36 (rezul'taty mnogotsentrovogo issledovaniya kachestva zhizni «Mirazh») [SF-36 questionnairy population quality of life indices]. Nauchno-prakticheskaya revmatologiya=Rheumatology Science and Practice, 2008, no. 1, pp. 36–48. (In Russ., Abstr. in Engl.)
2. Ivanov S.A., Gafanov R.A. Vozmozhnosti personalizirovannogo lecheniya kastratsionno-rezistentnogo raka predstatel'noi zhelezy [Opportunities for personalized treatment of castration-resistant prostate cancer]. RMJ=Russian Medical Journal, 2014, no. 17, p. 1285. (In Russ.)
3. Klinicheskie rekomendatsii. Rak predstatel'noi zhelezy [Prostate cancer. Clinical Guidelines]. Ministerstvo zdravookhraneniya Rossiiskoi Federatsii=Ministry of Health of the Russian Federation, 2021. 176 p. (In Russ.)
4. Koval'ski S.M., Shermer Dzh.A. Ustoichivost', perseverativnoe poznanie, trevoga i posledstviya, svyazannye so zdorov'em: dovody za i protiv psikhologicheskoi stoikosti [Hardiness, perseverative cognition, anxiety, and health-related outcomes: a case for and against psychological hardiness]. Psikhologicheskie otchety=Psychological Reports, 2019, Vol. 122, no 6., pp. 2096–2118. DOI: 10.1177/0033294118800444 (In Russ.)
5. Markova A.S., Polikarpova S.B., Kamolov B.Sh. [i dr.] Faktory prognoza obshchei vyzhivaemosti bol'nykh metastaticheskim kastratsionno-rezistentnym rakom predstatel'noi zhelezy [Predictors of overall survival in patients with metastatic castration-resistant prostate cancer]. Onkourologiya=Cancer Urology, 2015. Vol. 11, no. 2, pp. 77–84. DOI: 10.17650/1726-9776-2015-11-2-77-84 (In Russ., Abstr. in Engl.)
6. Matveev B.P., Bukharkin B.V. Lechenie gormonorezistentnogo raka predstatel'noi zhelezy [Treatment of hormone-resistant prostate cancer]. Sibirskii onkologicheskii zhurnal=Siberian Journal of Oncology, 2002, no. 3–4, pp. 15–21. (In Russ.)
7. Nasledov A.D. IBM SPSS Statistics 20 i AMOS: professional'nyi statisticheskii analiz dannykh [IBM SPSS Statistics 20 and AMOS: Professional statistical data analysis]. Saint Petersburg: Piter, 2013. 416 p. (In Russ.)
8. Padun M.A., Kotel'nikova A.V. Psikhicheskaya travma i kartina mira: Teoriya, empiriya, praktika [Psychic trauma and worldview: Theory, empirical study, practice]. Moscow: «Institut psikhologii RAN», 2012. 206 p. (In Russ.)
9. Psikhologicheskie testy dlya professionalov [Psychological tests for professionals]. Ed. N.F. Greben'. Minsk: Sovremennaya Shkola, 2007. 496 p. (In Russ.)
10. Seligman M. Novaya pozitivnaya psikhologiya: nauchnyi vzglyad na schast'e i smysl zhizni [The new positive psychology: a scientific view of happinness and the meaning of life]. Moscow: Sofiya, 2006. 367 p. (In Russ.)
11. Sergienko E.A. Psikhicheskoe razvitie s pozitsii sistemno-sub"ektnogo podkhoda [Mental development from the perspective of a system-subject approach]. Moscow: Publ. «Institut psikhologii RAN», 2021. 279 p. DOI: 10.38098/mng_21_0435 (In Russ.)
12. Tsiring D., Evnina K. Voprosy diagnostiki optimizma i pessimizma v kontekste teorii dispozitsionnogo optimizma [Issues of optimism and pessimism diagnostics in the context of dispositional optimism theory]. Psikhologicheskie issledovaniya=Psychological Studies. 2013. Vol. 6, no. 31. DOI: 10.54359/ps.v6i31.674 (In Russ.)
13. Assessing national capacity for the prevention and control of noncommunicable diseases: Report of the 2019 global survey. Geneva: World Health Organization, 2020.
14. de Martel C., Georges D., Bray F. et al. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Global Health, 2020. Vol. 8, no. 2, pp. 180–190. DOI: 10.1016/S2214-109X(19)30488-7
15. Ferlay J., Ervik M., Lam F., Colombet M. et al. Global cancer observatory: Cancer today. [Electronic resource]. Lyon: International Agency for Research on Cancer, 2020. URL: https://gco.iarc.fr/today (accessed: 20.12.2023).
16. Garcia R. Optimism, pessimism, and health. Encyclopedia of Behavioral Medicine. Eds. M.D. Gellman, J.R. Turner. NY: Springer, 2013. P. 1387–1389. DOI: 10.1007/978-3-030-39903-0_973
17. Jidveian Popescu M., Ciobanu A. Factors influencing delayed diagnosis in oncology. Maedica, 2020. Vol. 15, no. 2, pp. 191–195. DOI: 10.26574/maedica.2020.15.2.191
18. Kivima M., Vahtera J., Elovainio M. et al. Optimism and pessimism as predictors of change in health after death or onset of severe illness in family. Health Psychology, 2005. Vol. 24, no. 4, pp. 413–421. DOI: 10.1037/0278-6133.24.4.413
19. Kobasa S., Maddi S., Kahn S. Hardiness and health: a prospective study. Journal of Personality and Social Psychology, 1982. No. 42, pp. 168–177. DOI: 10.1037/0022-3514.42.1.168
20. Maddi S., Hightower M. Hardiness and optimism as expressed in coping patterns. Consulting Psychology Journal: Practice and Research, 1999, vol. 51, no. 2, pp. 95–105.
21. Petrova D., Okan Y., Salamanca-Fernández E. et al. Psychological factors related to time to help-seeking for cancer symptoms: A meta-analysis across cancer sites. Health Psychology Review, 2020. Vol. 14, no. 2, pp. 245–268. DOI: 10.1080/17437199.2019.1641425
22. Soerjomataram I., Bray F. Planning for tomorrow: Global cancer incidence and the role of prevention 2020–2070. Nature reviews. Clinical oncology, 2021. Vol. 18, no. 10, pp. 663–672. DOI: 10.1038/s41571-021-00514-z
23. Taylor K.L., Luta G., Zotou V. et al. Psychological predictors of delayed active treatment following active surveillance for low-risk prostate cancer: The Patient REported outcomes for Prostate cARE prospective cohort study. BJUI Compass, 2021. Vol. 3, no. 3, pp. 226–237. DOI: 10.1002/bco2.124
24. Wiebe D.J. Hardiness and health. Encyclopedia of Behavioral Medicine. Eds. M.D. Gellman, J.R. Turner. NY: Springer, 2013. Pp. 893–895. DOI: 10.1007/978-1-4419-1005-9_957 2